Cover Image
市場調查報告書

持續性過敏性鼻炎:全球臨床實驗檢討

Persistent Allergic Rhinitis Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 322164
出版日期 內容資訊 英文 61 Pages
訂單完成後即時交付
價格
Back to Top
持續性過敏性鼻炎:全球臨床實驗檢討 Persistent Allergic Rhinitis Global Clinical Trials Review, H2, 2014
出版日期: 2014年12月31日 內容資訊: 英文 61 Pages
簡介

本報告提供持續性過敏性鼻炎的臨床實驗相關之基本資料和數據,為您彙整實驗數量及受驗者的募集情況,各階段趨勢,進行臨床實驗的主要製藥企業及研究機關簡介等資料。

簡介

  • 持續性過敏性鼻炎
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區的主要5個國家的臨床實驗數量
    • 歐洲的主要國家的臨床實驗數量
    • 北美的主要國家的臨床實驗數量
    • 中東·非洲的主要國家的臨床實驗數量
    • 中南美的主要國家的臨床實驗數量

G7各國臨床實驗數量:呼吸系統疾病臨床實驗上持續性過敏性鼻炎所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:呼吸系統疾病臨床實驗上持續性過敏性鼻炎所佔的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

持續性過敏性鼻炎治療藥臨床實驗的主要參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Nuvo Research Inc.
    • J Uriach Y Compania, S.A.
    • Eurofarma Laboratorios S.A.
    • Theon Pharmaceuticals Ltd.
    • 武田藥品工業
    • Nuvo Research GmbH
    • EMS S.A.
    • Dong Wha Pharma Co., Ltd.
    • DCC Healthcare Limited
  • 有代表性的研究機關·醫院臨床實驗概要
    • Department of Health, South Africa
    • National Research Council of Thailand
    • Istituto Giannina Gaslini
    • The University of Sydney

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2506CTIDB

GlobalData's clinical trial report, "Persistant Allergic Rhinitis Global Clinical Trials Review, H2, 2014" provides data on the Persistant Allergic Rhinitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Persistant Allergic Rhinitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Persistant Allergic Rhinitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Persistant Allergic Rhinitis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Persistant Allergic Rhinitis to Respiratory Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Persistant Allergic Rhinitis to Respiratory Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Persistant Allergic Rhinitis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Persistant Allergic Rhinitis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Nuvo Research Inc.
      • Clinical Trial Overview of Nuvo Research Inc.
      • J Uriach Y Compania, S.A.
      • Clinical Trial Overview of J Uriach Y Compania, S.A.
      • Eurofarma Laboratorios S.A.
      • Clinical Trial Overview of Eurofarma Laboratorios S.A.
      • Theon Pharmaceuticals Ltd.
      • Clinical Trial Overview of Theon Pharmaceuticals Ltd.
      • Takeda Pharmaceutical Company Limited
      • Clinical Trial Overview of Takeda Pharmaceutical Company Limited
      • Nuvo Research GmbH
      • Clinical Trial Overview of Nuvo Research GmbH
      • EMS S.A.
      • Clinical Trial Overview of EMS S.A.
      • Dong Wha Pharma Co., Ltd.
      • Clinical Trial Overview of Dong Wha Pharma Co., Ltd.
      • DCC Healthcare Limited
      • Clinical Trial Overview of DCC Healthcare Limited
    • Clinical Trial Overview of Top Institutes / Government
      • Department of Health, South Africa
      • Clinical Trial Overview of Department of Health, South Africa
      • National Research Council of Thailand
      • Clinical Trial Overview of National Research Council of Thailand
      • Istituto Giannina Gaslini
      • Clinical Trial Overview of Istituto Giannina Gaslini
      • The University of Sydney
      • Clinical Trial Overview of The University of Sydney
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Persistant Allergic Rhinitis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Persistant Allergic Rhinitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Persistant Allergic Rhinitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials, Europe, Top Countries, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Persistant Allergic Rhinitis to Respiratory Clinical Trials, G7 Countries (%), 2014*
  • Persistant Allergic Rhinitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Persistant Allergic Rhinitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Persistant Allergic Rhinitis to Respiratory Clinical Trials, E7 Countries (%), 2014*
  • Persistant Allergic Rhinitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Persistant Allergic Rhinitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Persistant Allergic Rhinitis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Persistant Allergic Rhinitis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Persistant Allergic Rhinitis Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Persistant Allergic Rhinitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Nuvo Research Inc., 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by J Uriach Y Compania, S.A., 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Eurofarma Laboratorios S.A., 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Theon Pharmaceuticals Ltd., 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Nuvo Research GmbH, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by EMS S.A., 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Dong Wha Pharma Co., Ltd., 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by DCC Healthcare Limited, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, South Africa, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Research Council of Thailand, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Istituto Giannina Gaslini, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Sydney, 2014*

List of Figures

  • Persistant Allergic Rhinitis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Persistant Allergic Rhinitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials, Europe, Top Countries (%), 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of Persistant Allergic Rhinitis to Respiratory Clinical Trials, G7 Countries (%), 2014*
  • Persistant Allergic Rhinitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Persistant Allergic Rhinitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Persistant Allergic Rhinitis to Respiratory Clinical Trials, E7 Countries (%), 2014*
  • Persistant Allergic Rhinitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Persistant Allergic Rhinitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Persistant Allergic Rhinitis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Persistant Allergic Rhinitis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Persistant Allergic Rhinitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top